Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$412M |
| 2 |
Advanced Micro Devices
AMD
|
+$294M |
| 3 |
Apple
AAPL
|
+$244M |
| 4 |
Qualcomm
QCOM
|
+$207M |
| 5 |
Pinduoduo
PDD
|
+$180M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$510M |
| 2 |
Uber
UBER
|
+$419M |
| 3 |
Chevron
CVX
|
+$286M |
| 4 |
Meta Platforms (Facebook)
META
|
+$255M |
| 5 |
NVO
Novo Nordisk
NVO
|
+$215M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.64% |
| 2 | Healthcare | 18.28% |
| 3 | Consumer Discretionary | 13.73% |
| 4 | Industrials | 8.65% |
| 5 | Financials | 7.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2626
Neuronetics
STIM
$219M
| $580K | ﹤0.01% |
322,200
+178,700
| +125% | +$515K |
|
2627
Olema Pharmaceuticals
OLMA
$926M
| $576K | ﹤0.01% |
+53,200
| New | +$577K |
|
2628
Usio Inc
USIO
$76.7M
| $575K | ﹤0.01% |
375,656
-9,085
| -2% | -$14K |
|
|
BNT
2629
Brookfield Wealth Solutions
BNT
$11.9B
| $574K | ﹤0.01% |
20,700
-25,793
| -55% | -$717K |
|
2630
MicroSectors Gold Miners -3x Inverse Leveraged ETN
GDXD
$649M
| $573K | ﹤0.01% |
123
+101
| +459% | +$494K |
|
|
KLRS
2631
Kalaris Therapeutics
KLRS
$97.1M
| $572K | ﹤0.01% |
34,400
-3,056
| -8% | -$54K |
|
2632
Smart Sand
SND
$217M
| $571K | ﹤0.01% |
270,800
-10,100
| -4% | -$21.4K |
|
2633
OGE Energy
OGE
$9.81B
| $571K | ﹤0.01% |
16,000
-279,700
| -95% | -$9.82M |
|
2634
JPMorgan US Quality Factor ETF
JQUA
$8.63B
| $567K | ﹤0.01% |
10,700
-58,700
| -85% | -$3.04M |
|
2635
Five Point Holdings
FPH
$368M
| $566K | ﹤0.01% |
193,200
-1,500
| -0.8% | -$4.63K |
|
|
VXRT
2636
DELISTED
Vaxart
VXRT
| $566K | ﹤0.01% |
847,631
-76,669
| -8% | -$63.6K |
|
|
TRIB
2637
Trinity Biotech
TRIB
$8.07M
| $565K | ﹤0.01% |
8,848
-64
| -0.7% | -$3.73K |
|
2638
Gentherm
THRM
$1.35B
| $565K | ﹤0.01% |
11,464
-17,100
| -60% | -$884K |
|
|
AKRO
2639
DELISTED
Akero Therapeutics
AKRO
| $565K | ﹤0.01% |
+24,100
| New | +$515K |
|
2640
Pyxis Tankers
PXS
$52.3M
| $564K | ﹤0.01% |
110,795
+25,194
| +29% | +$123K |
|
2641
Monolithic Power Systems
MPWR
$68.1B
| $564K | ﹤0.01% |
686
-19,400
| -97% | -$14M |
|
|
ALLK
2642
DELISTED
Allakos
ALLK
| $562K | ﹤0.01% |
562,411
-293,307
| -34% | -$348K |
|
2643
iShares iBonds Dec 2028 Term Corporate ETF
IBDT
$4.07B
| $562K | ﹤0.01% |
+22,700
| New | +$560K |
|
2644
HBT Financial
HBT
$1.35B
| $562K | ﹤0.01% |
27,500
+14,400
| +110% | +$274K |
|
|
TRST
2645
Trustco Bank Corp NY
TRST
$972M
| $561K | ﹤0.01% |
19,486
+927
| +5% | +$25.5K |
|
2646
Bally's
BALY
$674M
| $560K | ﹤0.01% |
+46,797
| New | +$598K |
|
|
QIPT
2647
DELISTED
Quipt Home Medical
QIPT
| $560K | ﹤0.01% |
173,900
-111,500
| -39% | -$400K |
|
2648
Goldgroup Mining Inc.
GORO
$210M
| $559K | ﹤0.01% |
1,496,390
+95,300
| +7% | +$46.5K |
|
|
RSVR
2649
Reservoir Media
RSVR
$666M
| $559K | ﹤0.01% |
70,700
+40,600
| +135% | +$324K |
|
|
REFI
2650
Chicago Atlantic Real Estate Finance
REFI
$261M
| $558K | ﹤0.01% |
36,300
+5,400
| +17% | +$84.5K |
|
Similar funds
Jim Simons's Q2 2024 Portfolio in Review
As of Q2 2024, Jim Simons held 4,123 positions worth $59B, down 7.3% from $63.6B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons withdrew a net $4.49B in Q2 2024, closing 674 positions and reducing 1,503 holdings. Its most notable exit was Bank of America, an estimated $142M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Jim Simons opened a new position in Broadcom worth $472M.
- Jim Simons's largest Q2 2024 buy was Broadcom: 2,941,150 shares worth $472M.
- Jim Simons added most to Apple in Q2 2024, an estimated $244M increase.
- Jim Simons's biggest Q2 2024 reduction was Amazon, cutting an estimated $510M.
- Jim Simons fully exited Bank of America in Q2 2024, selling an estimated $142M.
- Jim Simons's ten largest holdings make up 12% of its $59B portfolio in Q2 2024.
- Jim Simons opened 463 new positions and closed 674 in Q2 2024.
- Jim Simons's portfolio value fell 7.3% quarter-over-quarter to $59B.
Based on Renaissance Technologies's 13F filing for Q2 2024, filed 9 Aug 2024.